World Medpharm Inc. v. York Region Standard Condominium Corporation No. 1279
2352711 Ontario Inc., cob as Enhanced Care Pharmacy Thornhill
2819826 Ontario Inc.
York Region Standard Condominium Corporation No. 1279
Law Firm / Organization
Not Specified
York Region Standard Condominium Corporation No. 1247
Law Firm / Organization
Dutton Brock LLP
World Medpharm Inc.
World Medpharm (2014) Inc., cob as World Pharmacy

Background

  • Locations: YRSCC 1247 and YRSCC 1279 at "World on Yonge," Yonge Street, Markham.
  • Issue: The Declarations of both condominiums require the Declarant's consent to operate a pharmacy.
  • Agreement: Medpharm had an Exclusive Use Agreement to operate the only pharmacy within "World on Yonge."
  • Violation: Enhanced Care operated a pharmacy without consent, claiming ignorance of the Declaration's terms.
  • Legal Action: Medpharm sought enforcement of the Declaration to stop Enhanced Care’s pharmacy operations.

Court Orders

  • Application Judge: Ordered Enhanced Care to cease operating the pharmacy and comply with the Declaration (Feb 27, 2024).
  • Appeal and Stay Motion: Enhanced Care appealed and sought a stay of the order pending appeal.

Legal Analysis

  1. Test for Stay Pending Appeal:

    • Serious Question: Appellants must show a serious question for appeal.
    • Irreparable Harm: Must prove harm that cannot be remedied if the stay is not granted.
    • Balance of Convenience: Weighs harm to both parties from granting or refusing the stay.
  2. Application of the Test:

    • Merits: The application judge's decision was discretionary and focused on clear prohibition of pharmacy use without consent. Appellants did not provide compelling grounds for appeal.
    • Irreparable Harm: No evidence of irreparable harm to appellants, only potential financial harm mitigated by indemnity agreements.
    • Balance of Convenience: No evidence of significant harm to Enhanced Care, and the status quo had been maintained for nearly two months.

Conclusion

  • Motion for Stay: Denied.
  • Costs: Appellants to pay $7,500 to Medpharm. No costs awarded for or against YRSCC 1247.
Court of Appeal for Ontario
M55094; COA-24-CV-0282
Real estate
$ 7,500
Respondent